Evidence suggesting that discontinuous dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors
- Amit Dipak Amin
- , Soumya S. Rajan
- , Winnie S. Liang
- , Praechompoo Pongtornpipat
- , Matthew J. Groysman
- , Edgar O. Tapia
- , Tara L. Peters
- , Lori Cuyugan
- , Jonathan Adkins
- , Lisa M. Rimsza
- , Yves A. Lussier
- , Soham D. Puvvada
- , Jonathan H. Schatz
Research output: Contribution to journal › Article › peer-review
31
Link opens in a new tab
Scopus
citations